B cell-based therapies in CNS autoimmunity: differentiating CD19 and CD20 as therapeutic targets

Increasing recognition of the role of B cells in the adaptive immune response makes B cells an important therapeutic target in autoimmunity. Numerous current and developmental immunotherapies target B cells for elimination through recognition of cell-surface proteins expressed specifically on B cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Forsthuber, Thomas G., Cimbora, Daniel M., Ratchford, John Nolan, Katz, Eliezer, Stüve, Olaf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865455/
https://www.ncbi.nlm.nih.gov/pubmed/29593838
http://dx.doi.org/10.1177/1756286418761697

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865455/
https://www.ncbi.nlm.nih.gov/pubmed/29593838
http://dx.doi.org/10.1177/1756286418761697

Ejemplares similares